Common Malaria Drug Repurposed to Fight Cancer
Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to fight cancer. Pyronaridine has been used to treat the mosquito-borne infectious disease for over 30 years.
3-Mar-2025 7:45 PM EST
Add to Favorites